1 not yet recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Placebo Nitazoxanide: new trials by email Literature Review of Placebo Nitazoxanide trials Research Report on Placebo Nitazoxanide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD Fecal Microbiota Transplant (FMT), Nitazoxanide 500mg BID, Vancomycin 250mg BID - ADHD, ADHD - Attention Deficit Disorder With Hyperactivity | Phase 2 | Not yet recruiting | University of Calgary | 64 | 2026-08-31 | 2026-09-10 |
| A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 Nitazoxanide, Placebo Nitazoxanide, Ribavirin - SARS-CoV Infection, Covid19 | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 7 | 2020-12-02 | 2022-05-05 |
Attention Deficit Disorder with Hyperactivity (1) · COVID-19 (1) · Neurodevelopmental Disorders (1) · Severe Acute Respiratory Syndrome (1)
Rutgers, The State University of New Jersey (1) · University of Calgary (1)
Canada (1) · United States (1)
Jeffrey L Carson, MD (1) · Thomas J Raedler, MD (1)